Prognostic impact of rapid reduction of involved free light chains in multiple myeloma patients under first-line treatment with Bendamustine, Prednisone, and Bortezomib (BPV) | SpringerLink
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Living With - HealthTree for Myeloma
The Answer, My Friend, is Flowing in the Blood: How to Monitor Treatment Response in Myeloma
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Frontiers | High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
VpreB surrogate light chain expression in B-lineage ALL: a report from the Children's Oncology Group - ScienceDirect
The Importance of Light Chain Levels for Multiple Myeloma Patients - HealthTree for Myeloma
The Proximal Tubule Toxicity of Immunoglobulin Light Chains - Kidney International Reports
Light chain multiple myeloma: Definition, diagnosis, and outlook
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis | HTML
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - Kidney International Reports
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
Immunoglobulin Kappa Chain - an overview | ScienceDirect Topics
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma | Blood Cancer Journal
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Free Light Chains as a Novel Diagnostic Biomarker of Immune System Abnormalities in Multiple Sclerosis and HIV Infection
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Evaluation of monoclonal gammopathies - Differential diagnosis of symptoms | BMJ Best Practice US
Serum-free light-chain assay: clinical utility and limitations - Malini V Bhole, Ross Sadler, Karthik Ramasamy, 2014
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
SciELO - Brasil - Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies Serum free light chain assays not total light chain
